Literature DB >> 25127846

Use of contrast-enhanced spectral mammography for intramammary cancer staging: preliminary results.

Katrin S Blum1, Christian Rubbert2, Britta Mathys2, Gerald Antoch2, Svjetlana Mohrmann3, Silvia Obenauer2.   

Abstract

RATIONALE AND
OBJECTIVES: To prospectively evaluate and compare the accuracy of contrast-enhanced spectral mammography (CESM) and ultrasound (US) in size measurement of breast cancer with histologic tumor sizes as gold standard.
MATERIALS AND METHODS: Twenty women aged between 40-73 years (mean age, 57 ± 10 years) with histologically proven invasive ductal/lobular carcinomas were included in the study. Agreement between imaging tumor size (CESM and US) and histopathologic tumor size was evaluated with Bland-Altman analysis. Stereotactically guided vacuum biopsy was performed in four patients after CESM. Two independent reviewers described artifacts of CESM.
RESULTS: Motion artifacts did not occur in the study. CESM-specific artifacts caused by scattered radiation mostly occurred in oblique view of CESM. Background enhancement of breast tissue was seen in four patients. Mean difference of tumor sizes was 0.3 mm (6.34%) between CESM and histology and -2.2 mm (-7.59%) between US and histology. Limits of agreement ranged from -18.9 to 19.48 mm for CESM and from -17.1 to 12.7 mm with US. Especially smaller tumors with a size <23 mm were measured more precisely with CESM. Enhancement of breast tissue around microcalcifications correlated with abnormalities.
CONCLUSIONS: CESM is accurate in size measurements of small breast tumors. On average CESM leads to a slight overestimation of tumor size, whereas US tends to underestimate tumor size. Assessment of the breast tissue can be limited by the scattered radiation artifact and background enhancement of breast tissue. CESM seems to be helpful in the characterization of breast tissue around microcalcifications.
Copyright © 2014 AUR. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Contrast-enhanced spectral mammography; artifacts; tumor staging; ultrasound

Mesh:

Substances:

Year:  2014        PMID: 25127846     DOI: 10.1016/j.acra.2014.06.012

Source DB:  PubMed          Journal:  Acad Radiol        ISSN: 1076-6332            Impact factor:   3.173


  11 in total

1.  Staging of breast cancer and the advanced applications of digital mammogram: what the physician needs to know?

Authors:  Maha H Helal; Sahar M Mansour; Mai Zaglol; Lamia A Salaleldin; Omniya M Nada; Marwa A Haggag
Journal:  Br J Radiol       Date:  2017-02-22       Impact factor: 3.039

2.  Diagnostic performance of contrast-enhanced dual-energy spectral mammography (CESM): a retrospective study involving 644 breast lesions.

Authors:  María Del Mar Travieso-Aja; Daniel Maldonado-Saluzzi; Pedro Naranjo-Santana; Claudia Fernández-Ruiz; Wilsa Severino-Rondón; Mario Rodríguez Rodríguez; Víctor Vega Benítez; Octavio Pérez-Luzardo
Journal:  Radiol Med       Date:  2019-06-27       Impact factor: 3.469

3.  The impact of contrast-enhanced spectral mammogram (CESM) and three-dimensional breast ultrasound (3DUS) on the characterization of the disease extend in cancer patients.

Authors:  Maha Hussien Helal; Sahar Mahmoud Mansour; Lamia Adel Salaleldin; Basma Mohamed Alkalaawy; Dorria Saleh Salem; Nadia Mahmoud Mokhtar
Journal:  Br J Radiol       Date:  2018-05-24       Impact factor: 3.039

4.  Contrast enhanced digital mammography versus magnetic resonance imaging for accurate measurement of the size of breast cancer.

Authors:  Inyoung Youn; SeonHyeong Choi; Yoon Jung Choi; Ju Hee Moon; Hee Jin Park; Soo-Youn Ham; Chan Heun Park; Eun Young Kim; Shin Ho Kook
Journal:  Br J Radiol       Date:  2019-04-24       Impact factor: 3.039

5.  Evaluation of low-energy contrast-enhanced spectral mammography images by comparing them to full-field digital mammography using EUREF image quality criteria.

Authors:  U C Lalji; C R L P N Jeukens; I Houben; P J Nelemans; R E van Engen; E van Wylick; R G H Beets-Tan; J E Wildberger; L E Paulis; M B I Lobbes
Journal:  Eur Radiol       Date:  2015-03-27       Impact factor: 5.315

Review 6.  The Changing World of Breast Cancer: A Radiologist's Perspective.

Authors:  Christiane K Kuhl
Journal:  Invest Radiol       Date:  2015-09       Impact factor: 6.016

7.  Contrast-Enhanced Mammography for Screening Women after Breast Conserving Surgery.

Authors:  Jill Gluskin; Carolina Rossi Saccarelli; Daly Avendano; Maria Adele Marino; Almir G V Bitencourt; Melissa Pilewskie; Varadan Sevilimedu; Janice S Sung; Katja Pinker; Maxine S Jochelson
Journal:  Cancers (Basel)       Date:  2020-11-24       Impact factor: 6.639

8.  Contrast-Enhanced Spectral Mammography: Importance of the Assessment of Breast Tumor Size.

Authors:  Luca Nicosia; Anna Carla Bozzini; Antuono Latronico; Enrico Cassano
Journal:  Korean J Radiol       Date:  2020-09-10       Impact factor: 3.500

9.  The Usefulness of Spectral Mammography in Surgical Planning of Breast Cancer Treatment-Analysis of 999 Patients with Primary Operable Breast Cancer.

Authors:  Andrzej Lorek; Katarzyna Steinhof-Radwańska; Anna Barczyk-Gutkowska; Wojciech Zarębski; Piotr Paleń; Karol Szyluk; Joanna Lorek; Anna Grażyńska; Paweł Niemiec; Iwona Gisterek
Journal:  Curr Oncol       Date:  2021-07-12       Impact factor: 3.677

10.  Accuracy of contrast-enhanced spectral mammography for estimating residual tumor size after neoadjuvant chemotherapy in patients with breast cancer: a feasibility study.

Authors:  Filipe Ramos Barra; Fernanda Freire de Souza; Rosimara Eva Ferreira Almeida Camelo; Andrea Campos de Oliveira Ribeiro; Luciano Farage
Journal:  Radiol Bras       Date:  2017 Jul-Aug
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.